However, withdraw from CPAP in both obese T2D and non-diabetics leads to an increase in nocturnal glucose without affecting glucose tolerance, production, or insulin (132), suggesting that CPAP use is leading to a reduction in glucose. The gene discussed is INS; the disease is type 2 diabetes mellitus.